![Angelika Goncalves DaSilva](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Angelika Goncalves DaSilva
Keine laufenden Positionen mehr
Karriereverlauf von Angelika Goncalves DaSilva
Ehemalige bekannte Positionen von Angelika Goncalves DaSilva
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TRILLIUM THERAPEUTICS | Geschäftsführer | 07.10.2010 | - |
Public Communications Contact | 07.10.2010 | 10.05.2012 |
Statistik
International
Kanada | 2 |
Operativ
Chief Operating Officer | 1 |
Public Communications Contact | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Trillium Therapeutics ULC
![]() Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |